Back

Chromatin readers orchestrate doxorubicin-induced endothelial senescence and paracrine cardiotoxicity: towards epi-drugs in cardio-oncology

28 August 2026 (13:15 - 13:27)
Organised by: Logo
Congress Presentation Part of: Endothelial dysfunction, senescence, and vascular ageing Stem Cells, Cell Cycle, Cell Senescence, Cell Death ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Shafeeq Ahmed Mohammed

University Hospital Zurich, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
Prostaglandin E2-EP2 signalling drives vascular aging by inducing mitochondrial dysfunction and pro-inflammatory phenotypic switching via QSOX1 up-regulation
Doctor J. Wang (Wuhan, CN)
Abstract Slides
Presentation thumbnail
An age-associated microRNA regulates angiogenic capacity and inflammatory signaling in endothelial senescence
Doctor K. Kalies (Halle, DE)
Abstract Slides
Presentation thumbnail
Single-cell analysis reveals inter-organ endothelial crosstalk in aging and obesity
Assistant Professor M. Yokoyama (Chiba, JP)
Abstract Slides
Presentation thumbnail
Endothelial GPR146 promotes blood pressure elevation by impairing endothelium-dependent vasodilation
Doctor S. Liu (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Endothelial dysfunction, senescence, and vascular ageing
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction
29 August 2025
thumbnail
Congress Presentation
Cardiac fibroblast activation in anthracycline related cardiac injury
1 September 2025
thumbnail
Congress Presentation
The functional role of TOP2beta PARylation in myeloid cells senescence-associated secretory phenotype (SASP) and atherosclerosis induction following ionizing radiation
20 June 2025
thumbnail
Congress Presentation
Novel epigenetic mapping in cell-free DNA for detection of changes during sodium glucose cotransporter 2 inhibitors (SGLT2I) treatment in heart failure patients
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources